Vigilant Capital Management, LLC Edwards Lifesciences Corp Transaction History

Vigilant Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 07, 2022	SELL	$101.96 - $128.34 $18,556 - $23,357	-182 Closed	0 $0
Q4 2021 Jan 06, 2022	SELL	$106.37 - $130.68 $46,802 - $57,499	-440 Reduced 70.74%	182 $24,000
Q3 2021 Oct 08, 2021	SELL	$102.91 - $122.75 $3,190 - $3,805	-31 Reduced 4.75%	622 $70,000
Q2 2021 Jul 09, 2021	BUY	$83.84 - $104.76 $54,747 - $68,408	653 New	653 $68,000
Q4 2018 Jan 15, 2019	SELL	$46.41 - $56.94 $2,784 - $3,416	-60 Closed	0 $0
Q2 2018 Jul 11, 2018	SELL	$42.45 - $51.3 $2,334 - $2,821	-55 Reduced 47.83%	60 $9,000
Q1 2018 Apr 04, 2018	BUY	$37.19 - $47.45 $2,045 - $2,609	55 Added 91.67%	115 $16,000
Q4 2017 Jan 31, 2018	BUY	$33.79 - $39.39 $2,027 - $2,363	60	60 $7,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vigilant Capital Management, LLC with notifications on news.